{"version":"1.0","type":"link","title":"Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.","author_name":"Yao Y 외","author_url":"https://prs-insight.online/author/Yao%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/166772","thumbnail_width":1200,"thumbnail_height":630}